VRC-MARADC087-00-VP

N/A

Report date: 2024/01/04 15:57:48

Base Information

Drug NameVRC-MARADC087-00-VP
Drug Alias NamecAd3-Marburg vaccine (ReiThera)VRC-MARADC087-00-VPChAd3-MARV
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsMarburg Virus DiseaseHemorrhagic Fever, Ebola
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUgandaKenya
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesNational Institute Of Allergy And Infectious Diseases (Niaid)Reithera Srl
China Registration ClassN/A

Develop Information

Active CompaniesThe Albert B. Sabin Vaccine Institute Inc
Inactive CompaniesNational Institute Of Allergy And Infectious Diseases (Niaid)
Active IndicationsMarburg Virus DiseaseHemorrhagic Fever, Ebola
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A